Civeo Corp 10-Q

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds The following table provides information about purchases of our common shares during the three months ended March 31, 2026. Total Number of Shares Purchased Average Price Paid per Share Total number of shares purchased as part of publicly announced plans or programs Maximum number of shares that may be purchased under the plans or programs January 1, 2026 - January 31, 2026 74,000 (1) $ 24.51 74,000 548,020 February 1, 2026 - February 28, 2026 443,439 (1) (2) $ 28.67 (3) 431,250 116,770 March 1, 2026 - March 31, 2026 5,750 (1) $ 27.93 5,750 111,020 Total 523,189 $ 28.06 511,000 111,020 (1) In April 2025, our Board authorized the repurchase of up to 20% of our total common shares which are issued and outstanding at that date, or approximately 2.7 million common shares (the 2025 Share Repurchase Program). Under the 2025 Share Repurchase Program, we may repurchase shares through a variety of methods, including but not limited to open market repurchases, pursuant to a Rule 10b5‑1 compliant plan, or privately negotiated transactions. We repurchased an aggregate of 511,000 of our common shares outstanding for approximately $14.4 million under the 2025 Share Repurchase Program during the three months ended March 31, 2026. In March 2026, our Board authorized an additional repurchase authorization of up to 10.0% of our common shares outstanding upon completion of the 2025 Share Repurchase Program. The 2025 Share Repurchase Program (including the additional authorization in March 2026) does not expire. (2) Includes 12,189 shares surrendered to us by participants in our 2014 Equity Participation Plan to settle the participants' personal tax liabilities that resulted from the lapsing of restrictions on shares awarded to the participants under the plan. (3) $27.67 per share was the closing price of our common shares on February 23, 2026, the respective date as of which the restrictions lapsed on such shares.